These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27842797)
1. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids. Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological studies of novel neurotensin(8-13) mimetics. Hong F; Zaidi J; Cusack B; Richelson E Bioorg Med Chem; 2002 Dec; 10(12):3849-58. PubMed ID: 12413837 [TBL] [Abstract][Full Text] [Related]
3. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia. Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400 [TBL] [Abstract][Full Text] [Related]
4. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain. Smith KE; Boules M; Williams K; Richelson E Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity. Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660 [TBL] [Abstract][Full Text] [Related]
7. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations. Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog. Chartier M; Desgagné M; Sousbie M; Rumsby C; Chevillard L; Théroux L; Haroune L; Côté J; Longpré JM; Boudreault PL; Marsault É; Sarret P Biomed Pharmacother; 2021 Sep; 141():111861. PubMed ID: 34229249 [TBL] [Abstract][Full Text] [Related]
9. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues. Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584 [TBL] [Abstract][Full Text] [Related]
10. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals. Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities. Lundquist JT; Büllesbach EE; Dix TA Bioorg Med Chem Lett; 2000 Mar; 10(5):453-5. PubMed ID: 10743946 [TBL] [Abstract][Full Text] [Related]
12. Neurotensin NTS Steele FF; Whitehouse SC; Aday JS; Prus AJ Brain Res; 2017 Mar; 1658():31-35. PubMed ID: 28089664 [TBL] [Abstract][Full Text] [Related]
13. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management. Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999 [TBL] [Abstract][Full Text] [Related]
14. Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand. Pratsch G; Unfried JF; Einsiedel J; Plomer M; Hübner H; Gmeiner P; Heinrich MR Org Biomol Chem; 2011 May; 9(10):3746-52. PubMed ID: 21472182 [TBL] [Abstract][Full Text] [Related]
15. Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand. Held C; Plomer M; Hübner H; Meltretter J; Pischetsrieder M; Gmeiner P ChemMedChem; 2013 Jan; 8(1):75-81. PubMed ID: 23097347 [TBL] [Abstract][Full Text] [Related]
16. Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics. Einsiedel J; Held C; Hervet M; Plomer M; Tschammer N; Hübner H; Gmeiner P J Med Chem; 2011 Apr; 54(8):2915-23. PubMed ID: 21446649 [TBL] [Abstract][Full Text] [Related]
17. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues. Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066 [TBL] [Abstract][Full Text] [Related]
18. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic. Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583 [TBL] [Abstract][Full Text] [Related]